Moxetumomab Pasudotox-tdfk and Pravastatin

• Generic Name: moxetumomab pasudotox
• Dosage Forms: n.a.
• Other Brand Names: Lumoxiti

Moxetumomab pasudotox-tdfk is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who received at least two prior systemic therapies, including treatment with a purine nucleoside analog (PNA).

Not recommended in patients with severe renal impairment (CrCl ≤ 29 mL/min).

• Generic Name: pravastatin
• Dosage Forms: n.a.
• Other Brand Names: Pravachol

Pravastatin is in a group of drugs called HMG CoA reductase inhibitors, or "statins."

Pravastatin is used together with diet to lower blood levels of "bad" cholesterol (low-density lipoprotein, or LDL), to increase levels of "good" cholesterol (high-density lipoprotein, or HDL), and to lower triglycerides (a type of fat in the blood).

Pravastatin is also used to lower the risk of stroke, heart attack, and other heart complications in people with or without coronary heart disease or other risk factors.

Pravastatin is used in adults and children who are at least 8 years old.